Candel Therapeutics (CADL) Debt Ratio (2020 - 2025)

Candel Therapeutics has disclosed Debt Ratio across 6 years of filings, most recently posting 0.01 for Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.01, down 92.01% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01 (down 92.01% YoY), and the FY2025 annual result was 0.01, down 92.01% from the prior year.
• Debt Ratio came in at 0.01 for Q4 2025 at Candel Therapeutics, down from 0.05 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.61 in Q1 2024 to a low of 0.01 in Q1 2022.
• The 5-year median for Debt Ratio is 0.24 (2022), against an average of 0.23.
• Across the five-year window, Debt Ratio jumped 5255.79% in 2023 and tumbled 92.01% in 2025, its largest moves.
• Candel Therapeutics' Debt Ratio stood at 0.01 in 2021, then soared by 4042.14% to 0.26 in 2022, then surged by 91.58% to 0.5 in 2023, then plunged by 79.78% to 0.1 in 2024, then plunged by 92.01% to 0.01 in 2025.
• The last three Debt Ratio figures came in at 0.01 (Q4 2025), 0.05 (Q3 2025), and 0.06 (Q2 2025), per Business Quant data.